Drugs / Beriplex® P/N
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00708435 | Jun 2008 → Nov 2010 | blood coagulation disease | CSL Behring | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beriplex P/N | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00708435 ↗ |
| Modality | Protein / enzyme biologic | “nonactivated 4-factor prothrombin complex concentrate (4F-PCC)” PMID 23935011 ↗ Aug 2013 |
| Route | Intravenous | “Intravenous infusion” NCT00708435 ↗ |